Member Login
Let Your Voice Be Heard!
Final Push Towards Victory! Your Voice Needed Now! Take action!
Make a difference in the challenge to confront global warming and prevent nuclear war and the development and use of nuclear weapons.
The future of the disarmament agenda is on the line now as New START ratification moves forward in the US Senate.
Back in June, PSR joined an appeal from a broad and unprecedented coalition of nuclear medical and nonproliferation groups urging Congress to fund domestic production of medical isotopes without bomb-grade uranium, to ensure supply of the isotopes while reducing risks of nuclear terrorism.
On October 29th, President Obama approved $20 million to jump-start U.S. domestic production of medical isotopes without the use of bomb-grade, highly enriched uranium (HEU), by signing into law the 2010 Energy and Water Appropriations bill.
The president and Congress acted in response to a sustained coalition effort led by Alan J. Kuperman, PhD,director of the Nuclear Proliferation Prevention Program at the University of Texas at Austin. "This is exactly what we were hoping for -- a kick-start of domestic production without the use of bomb-grade uranium, to both restore a reliable supply of isotopes and reduce risks of nuclear terrorism,” stated Dr. Kuperman.
Molybdenum-99 is an isotope whose decay product, Technecium-99m, is used in the majority of 20-million medical diagnostic procedures annually in the United States. For over two decades, the United States has imported its entire supply of this vital isotope from producers in Canada and Europe, who utilize bomb-grade uranium in the manufacturing process. Recent production interruptions at aging facilities in Canada and the Netherlands have cut U.S. supplies and increased prices, triggering a partial reversion to less effective and more invasive medical procedures.
The appropriations bill conference report states: "From within available resources, $20,000,000 shall be provided to accelerate the conversion of research reactors to support the domestic production of molybdenum-99."
Complementing this year's appropriation, the House Energy and Commerce Committee on October 21 approved the American Medical Isotopes Production Act of 2009, which authorizes $163 million over five years to "support projects for the production in the United States, without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses." The bill also phases out U.S. exports of bomb-grade uranium within seven years, to persuade foreign producers likewise to eliminate this risky material from their manufacturing processes.
The future of the disarmament agenda is on the line now as New START ratification moves forward in the US Senate.
Tell your elected officials to cut funding for new nuclear weapons building capacities and to fund key national priorities: clean energy, universal health care, and restoring our environment.
Towards Nuclear Abolition
The International Campaign to Abolish Nuclear Weapons (ICAN) wrote an excellent report after the Nuclear Non Proliferation Treaty Review Conference ended in May. It details the growing support from governments at the NPT-Review Conference for a Nuclear Weapons Convention. Read more »
Zero Is the Only Option
In March 2010, International Physicians for the Prevention of Nuclear War and PSR docs Vic Sidel and Ira Helfand published a major new briefing paper on the global climate and health effects of nuclear war. Zero is the only option was produced for the 2010 Non-Proliferation Treaty Review Conference. Read more »
Steps to Safety (for General Audiences)
PowerPoint presentation on how nuclear weapons put the United States at risk today--and how we can reduce and eventually eliminate the danger posed by the thousands of nuclear weapons still stockpiled in nuclear arsenals, the tons of nuclear bomb making material vulnerable to theft by extremists, and the specter of more nations potentially seeking nuclear weapons. Read more »
RSS Feed Privacy Policy Contact Us
All content © Copyright 2009 All rights reserved.
Comments